AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹50,860 Cr | ₹47,812 Cr | ₹48,590 Cr | ₹47,257 Cr | ₹40,098 Cr |
Sales | ₹50,109 Cr | ₹47,481 Cr | ₹48,238 Cr | ₹46,807 Cr | ₹39,719 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹513 Cr | ₹242 Cr | ₹135 Cr | ₹89 Cr | ₹41 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹238 Cr | ₹89 Cr | ₹217 Cr | ₹361 Cr | ₹338 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr | ₹23,099 Cr | ₹19,564 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-410 Cr | ₹817 Cr | ₹-730 Cr | ₹-102 Cr | ₹-676 Cr |
Raw Material Consumed | ₹10,600 Cr | ₹8,422 Cr | ₹9,558 Cr | ₹8,823 Cr | ₹8,562 Cr |
Opening Raw Materials | ₹2,378 Cr | ₹3,028 Cr | ₹2,434 Cr | ₹2,397 Cr | ₹2,228 Cr |
Purchases Raw Materials | ₹8,853 Cr | ₹5,817 Cr | ₹7,836 Cr | ₹6,827 Cr | ₹6,787 Cr |
Closing Raw Materials | ₹2,681 Cr | ₹2,374 Cr | ₹3,028 Cr | ₹2,513 Cr | ₹2,397 Cr |
Other Direct Purchases / Brought in cost | ₹2,050 Cr | ₹1,952 Cr | ₹2,315 Cr | ₹2,112 Cr | ₹1,943 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹843 Cr | ₹627 Cr | ₹589 Cr | ₹588 Cr | ₹557 Cr |
Electricity & Power | ₹843 Cr | ₹627 Cr | ₹589 Cr | ₹588 Cr | ₹557 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹3,522 Cr | ₹3,451 Cr | ₹3,535 Cr | ₹3,219 Cr | ₹2,585 Cr |
Salaries, Wages & Bonus | ₹3,073 Cr | ₹3,021 Cr | ₹3,070 Cr | ₹2,807 Cr | ₹2,251 Cr |
Contributions to EPF & Pension Funds | ₹159 Cr | ₹150 Cr | ₹144 Cr | ₹133 Cr | ₹109 Cr |
Workmen and Staff Welfare Expenses | ₹228 Cr | ₹213 Cr | ₹244 Cr | ₹226 Cr | ₹176 Cr |
Other Employees Cost | ₹62 Cr | ₹66 Cr | ₹78 Cr | ₹54 Cr | ₹49 Cr |
Other Manufacturing Expenses | ₹2,810 Cr | ₹2,503 Cr | ₹2,875 Cr | ₹2,331 Cr | ₹2,038 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹36 Cr | ₹27 Cr | ₹65 Cr | ₹69 Cr | ₹51 Cr |
Repairs and Maintenance | ₹384 Cr | ₹357 Cr | ₹336 Cr | ₹318 Cr | ₹286 Cr |
Packing Material Consumed | ₹1,103 Cr | ₹901 Cr | ₹1,075 Cr | ₹1,014 Cr | ₹826 Cr |
Other Mfg Exp | ₹1,287 Cr | ₹1,218 Cr | ₹1,400 Cr | ₹930 Cr | ₹875 Cr |
General and Administration Expenses | ₹1,387 Cr | ₹1,335 Cr | ₹1,474 Cr | ₹1,321 Cr | ₹1,007 Cr |
Rent , Rates & Taxes | ₹242 Cr | ₹227 Cr | ₹212 Cr | ₹217 Cr | ₹238 Cr |
Insurance | ₹121 Cr | ₹113 Cr | ₹89 Cr | ₹67 Cr | ₹42 Cr |
Printing and stationery | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹36 Cr | ₹30 Cr |
Professional and legal fees | ₹875 Cr | ₹872 Cr | ₹1,049 Cr | ₹884 Cr | ₹583 Cr |
Traveling and conveyance | ₹82 Cr | ₹53 Cr | ₹47 Cr | ₹87 Cr | ₹67 Cr |
Other Administration | ₹34 Cr | ₹38 Cr | ₹42 Cr | ₹31 Cr | ₹47 Cr |
Selling and Distribution Expenses | ₹1,686 Cr | ₹1,497 Cr | ₹1,564 Cr | ₹1,525 Cr | ₹1,126 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | ₹134 Cr | ₹280 Cr | ₹245 Cr | ₹217 Cr | ₹125 Cr |
Freight and Forwarding | ₹1,087 Cr | ₹773 Cr | ₹838 Cr | ₹683 Cr | ₹618 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹465 Cr | ₹444 Cr | ₹481 Cr | ₹625 Cr | ₹383 Cr |
Miscellaneous Expenses | ₹699 Cr | ₹420 Cr | ₹576 Cr | ₹530 Cr | ₹413 Cr |
Bad debts /advances written off | - | - | - | ₹6.94 Cr | ₹1.88 Cr |
Provision for doubtful debts | ₹52 Cr | - | ₹28 Cr | ₹62 Cr | ₹6.63 Cr |
Losson disposal of fixed assets(net) | - | ₹40 Cr | ₹141 Cr | ₹37 Cr | ₹19 Cr |
Losson foreign exchange fluctuations | ₹40 Cr | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹607 Cr | ₹380 Cr | ₹407 Cr | ₹424 Cr | ₹385 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr | ₹18,234 Cr | ₹15,612 Cr |
Operating Profit (Excl OI) | ₹3,719 Cr | ₹4,385 Cr | ₹5,333 Cr | ₹4,864 Cr | ₹3,952 Cr |
Other Income | ₹291 Cr | ₹323 Cr | ₹381 Cr | ₹192 Cr | ₹155 Cr |
Interest Received | ₹146 Cr | ₹32 Cr | ₹17 Cr | ₹18 Cr | ₹12 Cr |
Dividend Received | ₹2.63 Cr | ₹3.37 Cr | - | - | - |
Profit on sale of Fixed Assets | ₹13 Cr | - | - | - | - |
Profits on sale of Investments | - | ₹29 Cr | - | - | - |
Provision Written Back | ₹13 Cr | ₹68 Cr | ₹83 Cr | ₹26 Cr | ₹22 Cr |
Foreign Exchange Gains | - | ₹70 Cr | ₹104 Cr | ₹106 Cr | ₹40 Cr |
Others | ₹116 Cr | ₹121 Cr | ₹178 Cr | ₹42 Cr | ₹81 Cr |
Operating Profit | ₹4,009 Cr | ₹4,707 Cr | ₹5,714 Cr | ₹5,056 Cr | ₹4,107 Cr |
Interest | ₹140 Cr | ₹49 Cr | ₹74 Cr | ₹305 Cr | ₹263 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹18 Cr | ₹12 Cr |
Other Interest | ₹129 Cr | ₹37 Cr | ₹60 Cr | ₹287 Cr | ₹251 Cr |
PBDT | ₹3,869 Cr | ₹4,658 Cr | ₹5,640 Cr | ₹4,751 Cr | ₹3,845 Cr |
Depreciation | ₹1,245 Cr | ₹1,127 Cr | ₹1,055 Cr | ₹967 Cr | ₹668 Cr |
Profit Before Taxation & Exceptional Items | ₹2,624 Cr | ₹3,532 Cr | ₹4,584 Cr | ₹3,784 Cr | ₹3,177 Cr |
Exceptional Income / Expenses | - | ₹-128 Cr | ₹2,815 Cr | ₹-26 Cr | ₹-88 Cr |
Profit Before Tax | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr | ₹3,743 Cr | ₹3,091 Cr |
Provision for Tax | ₹685 Cr | ₹726 Cr | ₹2,010 Cr | ₹899 Cr | ₹727 Cr |
Current Income Tax | ₹1,071 Cr | ₹663 Cr | ₹2,322 Cr | ₹943 Cr | ₹712 Cr |
Deferred Tax | ₹-387 Cr | ₹63 Cr | ₹-312 Cr | ₹-44 Cr | ₹66 Cr |
Other taxes | - | - | - | - | ₹-51 Cr |
Profit After Tax | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr | ₹2,844 Cr | ₹2,365 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-0.15 Cr | ₹1.04 Cr | ₹1.02 Cr | ₹1.45 Cr | ₹0.23 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr | ₹2,845 Cr | ₹2,365 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹22,519 Cr | ₹20,137 Cr | ₹15,042 Cr | ₹12,399 Cr | ₹10,212 Cr |
Appropriations | ₹24,446 Cr | ₹22,785 Cr | ₹20,377 Cr | ₹15,244 Cr | ₹12,576 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | ₹13 Cr | ₹14 Cr |
Other Appropriation | ₹360 Cr | ₹2.25 Cr | ₹6.10 Cr | ₹13 Cr | - |
Equity Dividend % | ₹300.00 | ₹900.00 | ₹400.00 | ₹300.00 | ₹250.00 |
Earnings Per Share | ₹32.90 | ₹45.20 | ₹91.05 | ₹48.56 | ₹40.36 |
Adjusted EPS | ₹32.90 | ₹45.20 | ₹91.05 | ₹48.56 | ₹40.36 |
Compare Income Statement of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹75,521.4 Cr | 2.4% | 3.8% | 17.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 2.4% |
3.8% |
17.8% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses